These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 12032341)

  • 1. A therapeutic agent with oriented carbohydrates for treatment of infections by Shiga toxin-producing Escherichia coli O157:H7.
    Nishikawa K; Matsuoka K; Kita E; Okabe N; Mizuguchi M; Hino K; Miyazawa S; Yamasaki C; Aoki J; Takashima S; Yamakawa Y; Nishijima M; Terunuma D; Kuzuhara H; Natori Y
    Proc Natl Acad Sci U S A; 2002 May; 99(11):7669-74. PubMed ID: 12032341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of the optimal structure required for a Shiga toxin neutralizer with oriented carbohydrates to function in the circulation.
    Nishikawa K; Matsuoka K; Watanabe M; Igai K; Hino K; Hatano K; Yamada A; Abe N; Terunuma D; Kuzuhara H; Natori Y
    J Infect Dis; 2005 Jun; 191(12):2097-105. PubMed ID: 15897996
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Recent progress of Shiga toxin neutralizer for treatment of infections by Shiga toxin-producing Escherichia coli.
    Nishikawa K
    Arch Immunol Ther Exp (Warsz); 2011 Aug; 59(4):239-47. PubMed ID: 21644029
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral therapeutic agents with highly clustered globotriose for treatment of Shiga toxigenic Escherichia coli infections.
    Watanabe M; Matsuoka K; Kita E; Igai K; Higashi N; Miyagawa A; Watanabe T; Yanoshita R; Samejima Y; Terunuma D; Natori Y; Nishikawa K
    J Infect Dis; 2004 Feb; 189(3):360-8. PubMed ID: 14745692
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phylogenetic analysis and Shiga toxin production profiling of Shiga toxin-producing/enterohemorrhagic Escherichia coli clinical isolates.
    Li R; Harada T; Honjoh K; Miyamoto T
    Microb Pathog; 2010 Nov; 49(5):246-51. PubMed ID: 20558273
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Escherichia coli O157:H7 infections: discordance between filterable fecal shiga toxin and disease outcome.
    Cornick NA; Jelacic S; Ciol MA; Tarr PI
    J Infect Dis; 2002 Jul; 186(1):57-63. PubMed ID: 12089662
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relative nephroprotection during Escherichia coli O157:H7 infections: association with intravenous volume expansion.
    Ake JA; Jelacic S; Ciol MA; Watkins SL; Murray KF; Christie DL; Klein EJ; Tarr PI
    Pediatrics; 2005 Jun; 115(6):e673-80. PubMed ID: 15930195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence, virulence profiles, and clinical significance of Shiga toxin-negative variants of enterohemorrhagic Escherichia coli O157 infection in humans.
    Friedrich AW; Zhang W; Bielaszewska M; Mellmann A; Köck R; Fruth A; Tschäpe H; Karch H
    Clin Infect Dis; 2007 Jul; 45(1):39-45. PubMed ID: 17554698
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and assessment of globotriose-chitosan conjugate, a novel inhibitor of shiga toxins produced by Escherichia coli.
    Li X; Wu P; Cheng S; Lv X
    J Med Chem; 2012 Mar; 55(6):2702-10. PubMed ID: 22372889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Study on diarrhea disease caused by enterohemorrhagic Escherichia coli O157:H7 in Xuzhou city, Jiangsu province in 2000].
    Li H; Jing H; Pang B; Zhao G; Yang J; Xu J
    Zhonghua Liu Xing Bing Xue Za Zhi; 2002 Apr; 23(2):119-22. PubMed ID: 12015094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Escherichia coli O157:H7 and non-O157 Shiga toxin-producing E. coli in healthy cattle, sheep and swine herds in Northern Spain.
    Oporto B; Esteban JI; Aduriz G; Juste RA; Hurtado A
    Zoonoses Public Health; 2008; 55(2):73-81. PubMed ID: 18234025
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Isolation of Escherichia coli O157:H7 strains that do not produce Shiga toxin from bovine, avian and environmental sources.
    Wetzel AN; Lejeune JT
    Lett Appl Microbiol; 2007 Nov; 45(5):504-7. PubMed ID: 17908226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A multivalent peptide library approach identifies a novel Shiga toxin inhibitor that induces aberrant cellular transport of the toxin.
    Nishikawa K; Watanabe M; Kita E; Igai K; Omata K; Yaffe MB; Natori Y
    FASEB J; 2006 Dec; 20(14):2597-9. PubMed ID: 17065223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Shiga toxin-producing Escherichia coli in children with diarrhea: a prospective point-of-care study.
    Klein EJ; Stapp JR; Clausen CR; Boster DR; Wells JG; Qin X; Swerdlow DL; Tarr PI
    J Pediatr; 2002 Aug; 141(2):172-7. PubMed ID: 12183710
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of enterohemorrhagic Escherichia coli O157:H7 00B015: a Shiga toxin producing but virulence-attenuated isolate.
    Wang H; Gu J; Yu S; Zhang W; Zhu Y; Zou Q; Zhu F; Mao X
    Can J Microbiol; 2010 Aug; 56(8):651-6. PubMed ID: 20725127
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bovine immune response to shiga-toxigenic Escherichia coli O157:H7.
    Hoffman MA; Menge C; Casey TA; Laegreid W; Bosworth BT; Dean-Nystrom EA
    Clin Vaccine Immunol; 2006 Dec; 13(12):1322-7. PubMed ID: 17050743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Production of Shiga-like toxins in viable but nonculturable Escherichia coli O157:H7.
    Liu Y; Wang C; Tyrrell G; Li XF
    Water Res; 2010 Feb; 44(3):711-8. PubMed ID: 19879621
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of probiotic treatment with Clostridium butyricum on enterohemorrhagic Escherichia coli O157:H7 infection in mice.
    Takahashi M; Taguchi H; Yamaguchi H; Osaki T; Komatsu A; Kamiya S
    FEMS Immunol Med Microbiol; 2004 Jul; 41(3):219-26. PubMed ID: 15196571
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antimicrobial resistance of Shiga toxin (verotoxin)-producing Escherichia coli O157:H7 and non-O157 strains isolated from humans, cattle, sheep and food in Spain.
    Mora A; Blanco JE; Blanco M; Alonso MP; Dhabi G; Echeita A; González EA; Bernárdez MI; Blanco J
    Res Microbiol; 2005 Aug; 156(7):793-806. PubMed ID: 15921895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [New drugs that prevent cytotoxicity of Shiga toxins].
    Natori Y
    Nihon Rinsho; 2002 Jun; 60(6):1131-7. PubMed ID: 12078085
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.